<qa>  What is the effect of lipid lowering therapy in secondary prevention of cardiovascular events?MEGA study has shown that lipid lowering therapy with pravastatin 10-20 mgday was associated with a 33 reduction in coronary heart disease incidence as the primary prevention in Japanese patients. However, the effect of lipid lowering therapy in secondary prevention of cardiovascular events is unknown. 